Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02922153 · ClinicalTrials.gov registry record · NA

The cryoICE™ CryoAnalgesia Study For Pain Management in Post thoRacic Procedures Via intercOSTal Cryoanalgesia (FROST)

A NA study of Pain, sponsored by AtriCure.

Completed
Registry status
NA
Development phase
84
Enrollment target
5
Study locations

NCT02922153 is a NA study of Pain that has completed, run by AtriCure. The registered enrollment target is 84 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (72% lower). The trial reports 5 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02922153, a NA study of Pain, has completed, sponsored by AtriCure.

COMPLETED
Registry status
NA
Development phase
84 participants
Enrollment target
5
Study locations

Study Summary

The investigators propose to assess whether intra-operative intercostal cryoanalgesia using the cryoICE® probe (AtriCure®, Inc., 7555 Innovation Way, Mason, Ohio) provides superior post-operative analgesic efficacy as compared to current pain management in patients undergoing unilateral thoracotomy cardiac procedures.

Conditions Studied

Interventions

  • DRUG Standard of Care
  • DEVICE Cryoanalgesia

Study Locations (5)

Michigan

  • University of Michigan - Ann Arbor
  • William Beaumont Hospital - Royal Oak

California

  • University of Southern California (USC) - Los Angeles

Minnesota

  • United Heart and Vascular Institute - Allina - Saint Paul

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2016-06-13
Est. Completion 2019-08-28
Phase NA

Sponsor

AtriCure

23 total trials

What the Registry Record Tells You About NCT02922153

The ClinicalTrials.gov registry entry for NCT02922153 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (72% lower). The listed sponsor is AtriCure, which has 23 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.

NCT02922153 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Michigan, California, Minnesota.

Frequently Asked Questions

What is clinical trial NCT02922153 about?

NCT02922153 is a clinical study titled "The cryoICE™ CryoAnalgesia Study For Pain Management in Post thoRacic Procedures Via intercOSTal Cryoanalgesia (FROST)". The investigators propose to assess whether intra-operative intercostal cryoanalgesia using the cryoICE® probe (AtriCure®, Inc., 7555 Innovation Way, Mason, Ohio) provides superior post-operative analgesic efficacy as compared to current pain management in patients undergoing unilateral thoracotomy ...

What is the current status of trial NCT02922153?

This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2016-06-13. Estimated completion is 2019-08-28.

What conditions does trial NCT02922153 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT02922153?

The interventions under investigation include: Standard of Care (DRUG), Cryoanalgesia (DEVICE).

Who is sponsoring clinical trial NCT02922153?

This trial is sponsored by AtriCure, which has 23 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02922153 being conducted?

This trial has 5 study locations across California, Michigan, Minnesota, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.